Clinical Data:

• Mahana IBS is FDA cleared and has undergone randomized clinical trials.
• A randomized clinical trial found that participants using Mahana IBS had significant reductions in symptoms of IBS, including abdominal pain and bloating, compared to those in a control group.
• Another study found that Mahana IBS improved quality of life for patients with IBS.

Mechanism:

• Uses a combination of behavioral therapy, mindfulness techniques, and personalized coaching to help users manage their IBS symptoms.

Safety and Side Effects:

• There are no reported safety concerns or side effects associated with using Mahana IBS.

Patient Eligibility:

• Mahana IBS is designed for individuals with irritable bowel syndrome (IBS).

‍